Business Combinations (Tables)

9 Months Ended

Jul. 01, 2017

The purchase price consideration was as follows:



Cash paid	$	1,578.6
Accrued liability relating to dissenting shareholders	79.2
Total purchase price	$	1,657.8

Purchase Price Allocation

The preliminary purchase price allocation is as follows:



Cash	$	107.2
Marketable securities	82.9
Accounts receivable	40.2
Inventory	121.1
Property, plant and equipment	44.1
Other assets and liabilities, net	13.3
Accounts payable and accrued expenses	(74.5		)
Deferred revenue	(11.2		)
Capital lease obligation	(25.2		)
Identifiable intangible assets:
Developed technology	736.0
In-process research and development	107.0
Distribution agreement	42.0
Customer relationships	35.0
Trade names	74.0
Deferred income taxes, net	(313.6		)
Goodwill	679.5
Purchase Price	$	1,657.8

Pro Forma Information

The following unaudited pro forma information presents the combined financial results for the Company and Cynosure as if the acquisition of Cynosure had been completed at the beginning of the prior fiscal year, September 26, 2015:



	Nine Months Ended		Nine Months Ended
	July 1, 2017		June 25, 2016
	(unaudited)		(unaudited)
Revenue	$	2,438.5	$	2,411.6
Net income	$	671.4	$	168.6
Basic earnings per common share	$	2.40	$	0.60
Diluted earnings per common share	$	2.35	$	0.59